BIO
Bio-Rad Laboratories Inc
NYSE: BIO · HEALTHCARE · MEDICAL DEVICES
$385.12
+1.08% today
Updated 2026-10-28
Market cap
$9.46B
P/E ratio
44.83
P/S ratio
3.65x
EPS (TTM)
$7.89
Dividend yield
—
52W range
$237 – $396
Volume
0.3M
Bio-Rad Laboratories Inc (BIO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$385.12
12-Month target
$271.22
2030 Target
—
Intrinsic (DCF)
$204.33
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.7B | $2.6B | $2.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 8.59%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.